adenovirus vector vaccine (International AIDS Vaccine Initiative/GlaxoSmithKline)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadenovirus vector vaccine (International AIDS Vaccine Initiative/GlaxoSmithKline)
Drug Alias Nameadenovirus vector vaccine (IAVI/GSK)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInternational Aids Vaccine Initiative
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcInternational Aids Vaccine Initiative
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A